|
6-(4-氯苯基)吡嗪-2-甲酸
|
R036732-250mg
|
95% |
1258850-50-8 |
250mg
|
¥ 759.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036731-100mg
|
≥98%,99%e.e. |
1258327-08-0 |
100mg
|
¥ 2463.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036730-100mg
|
≥98%,99%e.e. |
1258327-07-9 |
100mg
|
¥ 2950.0
|
现货 |
|
0 |
罗恩 |
|
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036729-100mg
|
≥98%,99%e.e. |
1258327-06-8 |
100mg
|
¥ 2509.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036729-50mg
|
≥98%,99%e.e. |
1258327-06-8 |
50mg
|
¥ 1757.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036728-100mg
|
≥95%,99%e.e. |
1258327-05-7 |
100mg
|
¥ 2413.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036727-100mg
|
≥98%,99%e.e. |
1258327-04-6 |
100mg
|
¥ 2233.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(S)-螺环二酚膦酸酯
|
R036726-100mg
|
≥98%,99%e.e. |
1258327-03-5 |
100mg
|
¥ 274.0
|
现货 |
|
0 |
罗恩 |
|
(S)-2,2',3,3'-Tetrahydro-6,6'-di(1-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
R036725-100mg
|
≥98%,99%e.e. |
1258327-02-4 |
100mg
|
¥ 3100.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(S)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
R036724-100mg
|
≥98%,99%e.e. |
1258327-01-3 |
100mg
|
¥ 2626.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
R036723-100mg
|
≥98%,99%e.e. |
1258327-00-2 |
100mg
|
¥ 4056.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(S)-6,6'-Bis(4-chlorophenyl)-2,2',3,3'-tetrahydro-1,1'spirobi[1H-indene]-7,7'-diol
|
R036722-100mg
|
≥98%,99%e.e. |
1258326-99-6 |
100mg
|
¥ 2264.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(S)-2,2',3,3'-Tetrahydro-6,6'-diphenyl-1,1'-spirobi[1H-indene]-7,7'-diol
|
R036721-100mg
|
≥98%,99%e.e. |
1258326-98-5 |
100mg
|
¥ 2388.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
2,6-二氯-4-碘苯甲酸
|
R036720-250mg
|
98% |
1258298-01-9 |
250mg
|
¥ 455.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
2,6-二氯-4-碘苯甲酸
|
R036720-50mg
|
98% |
1258298-01-9 |
50mg
|
¥ 229.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
5-溴-2-甲基吡啶-4-醇
|
R036719-50mg
|
97% |
1258287-39-6 |
50mg
|
¥ 155.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
1-(3-氟苯基)环己胺
|
R036718-1g
|
≥97% |
125827-86-3 |
1g
|
¥ 2356.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
1-(3-氟苯基)环己胺
|
R036718-250mg
|
≥97% |
125827-86-3 |
250mg
|
¥ 833.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
R036717-100mg
|
≥98%,99%e.e. |
1258276-28-6 |
100mg
|
¥ 3280.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
6-[4-(三氟甲氧基)苯基]吡嗪-2-甲酸
|
R036716-1g
|
95% |
1258269-13-4 |
1g
|
¥ 2429.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
6-[4-(三氟甲氧基)苯基]吡嗪-2-甲酸
|
R036716-250mg
|
95% |
1258269-13-4 |
250mg
|
¥ 910.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
1-苯基环庚基胺盐酸盐
|
R036715-1g
|
95% |
125802-37-1 |
1g
|
¥ 193.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
1-苯基环庚基胺盐酸盐
|
R036715-250mg
|
95% |
125802-37-1 |
250mg
|
¥ 63.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
3-溴-4-甲基-1H-吡唑-5-羧酸乙酯
|
R036714-100mg
|
95% |
1257861-04-3 |
100mg
|
¥ 102.0
|
现货 |
|
0 |
罗恩 |